Global Pain Management Device Market Overview: 2025-2030
Base Year: 2024
Historical Years: 2020-23
Forecast Years: 2025-2030
The Global Pain Management Devices Market size was valued at around USD 3,808 million in 2024 and is projected to reach USD 6,500 million by 2030. Along with this, the market is also estimated to grow at a CAGR of around 9.3% during the forecast period, i.e., 2025-30.
Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report – https://www.marknteladvisors.com/query/request-sample/pain-management-device-market.html
Global Pain Management Device Market Dynamics: 2025-2030
Global Pain Management Devices Market Driver:
Increasing Prevalence of Chronic Pain Driving Demand – Chronic pain is a significant health problem that affects millions of people worldwide and forces them to seek efficient solutions for pain management. For instance, as per data from 2021 by the Centers for Disease Control and Prevention in the US, around 20.9% of adults are affected by chronic pain, creating a high requirement for pain management. Around 6.9% of them, estimated at 17.1 million individuals, had high-impact chronic pain severe enough to interfere with daily life.
Also in 2023, the incidence of new chronic pain cases was reported at 52.4 cases per 1,000 people per year, which indicates an increasing public health challenge. With a rise in chronic pain, safer pain management devices are being adopted instead of opioids, further driving the market growth. The non-invasive or minimally invasive solutions provided by these devices enable patients to manage their pain effectively while limiting the risks associated with long-term usage of opioids. The rise in the focus on non-pharmacological treatments to avoid the prevalence of chronic pain is also hastening the advancement in pain management technologies.
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/pain-management-device-market.html
Global Pain Management Device Market (2025-30): Segmentation Outlook
The market report has segmented the market into the following categories:
By Device Type
-Neuromodulation & Neurostimulation Devices-Market Size & Forecast 2019-2030, USD Million
-Analgesic Infusion Pumps-Market Size & Forecast 2019-2030, USD Million
-Intrathecal Infusion Pumps- Market Size & Forecast 2020-2030, (USD Million)
-External Infusion Pumps-Market Size & Forecast 2020-2030, (USD Million)
-Ablation Devices-Market Size & Forecast 2019-2030, USD Million
-Radiofrequency Ablation Devices- Market Size & Forecast 2020-2030, (USD Million)
-Cryoablation Devices-Market Size & Forecast 2020-2030, (USD Million)
-Neurothrombectomy Devices-Market Size & Forecast 2019-2030, USD Million
-Radiofrequency Ablation Devices- Market Size & Forecast 2020-2030, (USD Million)
-Cryoablation Devices-Market Size & Forecast 2020-2030, (USD Million)
Based on device type, neuromodulation and neurostimulation devices have the largest market share, around 40%.
By Application
-Neuropathic Pain-Market Size & Forecast 2020-2030, USD Million
-Cancer Pain-Market Size & Forecast 2020-2030, USD Million
-Facial & Migraine Pain-Market Size & Forecast 2020-2030, USD Million
-Musculoskeletal Pain-Market Size & Forecast 2020-2030, USD Million
-Others-Market Size & Forecast 2020-2030, USD Million
By End-User
-Hospital & Clinics-Market Size & Forecast 2020-2030, USD Million
-Physiotherapy Centers-Market Size & Forecast 2020-2030, USD Million
-Rehabilitation Centers-Market Size & Forecast 2020-2030, Thousand
By Region
-North America
-South America
-Europe
-The Middle East & Africa
-Asia-Pacific.
North America has the largest market share, around 40%. This is because of the increased frequency of chronic diseases in this region.
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Top Companies Operating in the Global Pain Management Device Market:
Abbott Laboratories, Smith’s Medical, B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., Colfax Corp., Medtronic plc, Nevro Corp., Stryker, Omron Corporation, Stimwave LLC, Kimberly-Clark Corporation, DJO Global LLC, Motive Health, Inc., Koninklijke Philips NV, Others.
Industry Recent Development:
- In April 2024, Medtronic (Ireland) got FDA approval for its Inceptive spinal cord stimulator, a rechargeable device that helps treat chronic pain using closed-loop technology.
- May 2023: Abbott announced that the U.S. Food and Drug Administration (FDA) approved its spinal cord stimulation (SCS) devices for the treatment of chronic back pain patients who are not ready or eligible to receive back surgery, known as non-surgical back pain.
Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
